Shen, R., Xu, P.P., Wang, N., Yi, H.M., Dong, L., Fu, D., Huang, J.Y., Huang, H.Y., Janin, A., Cheng, S., Wang, L., Zhao, W.L. (2020) Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. Clinical and translational medicine. 10:e221
|
Xu, P.P., Sun, Y.F., Fang, Y., Song, Q., Yan, Z.X., Chen, Y., Jiang, X.F., Fei, X.C., Zhao, Y., Leboeuf, C., Li, B., Wang, C.F., Janin, A., Wang, L., Zhao, W.L. (2017) JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide. Scientific Reports. 7:7433
|
Zhang, K., Huang, L., Lai, F., Lin, S., Tian, H., Wu, D., Chena, X., Xu, H. (2022) Bioevaluation of a dual PI3K/HDAC inhibitor for the treatment of diffuse large B-cell lymphoma. Bioorganic & medicinal chemistry letters. 71:128825
|
